Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Olufunlayo Osayameh"'
Autor:
Patricia Rich, Richard L. Schilsky, Seungjean Chai, Susan Halabi, Kaitlyn R. Antonelli, Elizabeth Garrett-Mayer, Pam K. Mangat, Olufunlayo Osayameh, Tareq Al Baghdadi, Eugene R Ahn, Andrew L. Rygiel, Samiha Islam, Suanna S. Bruinooge
Publikováno v:
Targeted Oncology. 15:743-750
TAPUR is a pragmatic, phase II basket study evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancers harboring genomic alterations known to be drug targets. Sunitinib is an oral multikinase inhibit
Autor:
Tareq, Al Baghdadi, Elizabeth, Garrett-Mayer, Susan, Halabi, Pam K, Mangat, Patricia, Rich, Eugene R, Ahn, Seungjean, Chai, Andrew L, Rygiel, Olufunlayo, Osayameh, Kaitlyn R, Antonelli, Samiha, Islam, Suanna S, Bruinooge, Richard L, Schilsky
Publikováno v:
Targeted oncology. 15(6)
TAPUR is a pragmatic, phase II basket study evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancers harboring genomic alterations known to be drug targets. Sunitinib is an oral multikinase inhibit
Autor:
Ana M. Rule, Aaron Pankiewicz, Dorota Szymkowiak, Michelle Shuster, Giridhar Mallya, Olufunlayo Osayameh, Ann C. Klassen, Maxwell Boamah, Virginius Bragg, Nora L. Lee, Anita Wade, Bethany Townsend Ogbenna, Rikki L. Ward, Ryan Coffman
Publikováno v:
Tobacco Regulatory Science. 3:192-203
Objectives Multi-unit housing environments remain significant sources of secondhand smoke (SHS) exposure, especially for vulnerable populations in subsidized housing. In Philadelphia, the largest US housing authority to implement smoke-free policies,
Autor:
Pam K. Mangat, Elizabeth Garrett-Mayer, Olufunlayo Osayameh, Eugene R Ahn, Eyal Meiri, Susan Halabi, Venu Perla, Richard L. Schilsky, Sagun Shrestha
Publikováno v:
Journal of Clinical Oncology. 38:133-133
133 Background: TAPUR is a phase II basket study evaluating anti-tumor activity of commercially available targeted agents in pts with advanced cancers with genomic alterations. Results in a cohort of CRC pts with HTMB treated with P are reported. Met